MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer

author
created [InstanceEdit:9660740] Orlic-Milacic, Marija, 2019-09-11
dbId 9660747
displayName MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer
journal Med. Oncol.
pages 1066-72
pubMedIdentifier 19862647
schemaClass LiteratureReference
title MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer
url http://www.ncbi.nlm.nih.gov/pubmed/19862647
volume 27
year 2010
Cite Us!